Table IV.

Effects of Hypertension on Main Outcomes at 30 Days and 1 Year

	At 30 Days				At 1 year
Outcomes	No. Events/Observations	Z Value	Adjusted* OR [95% CI]	p Value	No. Events/Observations	Z Value	Adjusted* HR [95% CI]	p Value
Death/myocardial infarction	675/12,128	4.38	1.61 [1.30–1.99]	<0.001	1,160/12,016	5.32	1.54 [1.31–1.81]	<0.001
Death/myocardial infarction/recurrent ischemia	1,895/12,128	4.18	1.30 [1.15–1.47]	<0.001	3,032/12,038	5.43	1.29 [1.18–1.42]	<0.001
Death	275/12,128	3.07	1.72 [1.21–2.42]	0.002	574/11,998	4.35	1.70 [1.34–2.16]	<0.001
Myocardial infarction	479/12,128	3.75	1.61 [1.25–2.06]	<0.001	742/11,944	4.02	1.50 [1.23–1.82]	<0.001
Recurrent ischemia	1,413/12,046	3.37	1.26 [1.10–1.44]	0.001	2,278/11,975	3.94	1.24 [1.11–1.38]	<0.001
Major bleeding	237/5971	2.1	1.45 [1.03–2.06]	0.036	–	–	–	–
OR=odds ratio; CI=confidence interval; *parameters adjusted for included gender, age per 10‐year increase, ethnicity, smoking status, prior myocardial infarction, history of hypertension, diabetes, percutaneous coronary intervention, diagnosis on admission (non–ST‐segment elevation myocardial infarction vs. unstable angina), ST‐segment deviation, systolic and diastolic blood pressure, heart rate on admission, as well as creatinine clearance per 10‐unit increase